Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing Type
4
Filing Date
5/5/2025
Updated
5/6/25, 3:05 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership